Comprehensive genomic sequencing of paired ovarian cancers reveals discordance in genes that determine clinical trial eligibility

Julia E. Fehniger, Amnon A. Berger, Luke Juckett, Julia Elvin, Douglas A. Levine, Deborah A. Zajchowski

Open source

DOI
10.1016/j.ygyno.2019.10.004
Published
2019-12
Container
Gynecologic Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ygyno.2019.10.004,
  title = {Comprehensive genomic sequencing of paired ovarian cancers reveals discordance in genes that determine clinical trial eligibility},
  author = {Julia E. Fehniger and Amnon A. Berger and Luke Juckett and Julia Elvin and Douglas A. Levine and Deborah A. Zajchowski},
  year = {2019},
  journal = {Gynecologic Oncology},
  doi = {10.1016/j.ygyno.2019.10.004},
  url = {https://doi.org/10.1016/j.ygyno.2019.10.004}
}

RIS

TY  - JOUR
TI  - Comprehensive genomic sequencing of paired ovarian cancers reveals discordance in genes that determine clinical trial eligibility
AU  - Julia E. Fehniger
AU  - Amnon A. Berger
AU  - Luke Juckett
AU  - Julia Elvin
AU  - Douglas A. Levine
AU  - Deborah A. Zajchowski
PY  - 2019
JO  - Gynecologic Oncology
DO  - 10.1016/j.ygyno.2019.10.004
UR  - https://doi.org/10.1016/j.ygyno.2019.10.004
ER  - 

APA

Fehniger, J. E., Berger, A. A., Juckett, L., Elvin, J., Levine, D. A., & Zajchowski, D. A. (2019). Comprehensive genomic sequencing of paired ovarian cancers reveals discordance in genes that determine clinical trial eligibility. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2019.10.004

Source records